Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1101 (17 May), doi:10.1136/bmj.39580.445856.59
Nicholas A Christakis, professor of medical sociology, Harvard Medical School, and attending physician (with an emphasis on palliative medicine), Mt Auburn Hospital, Cambridge, Massachusetts
christak@hcp.med.harvard.edu
The prospect of medical technology modifying genetic evolution is as amazing as it is troubling
| The first 150 words of the full text of this article appear below. |
A lot of hot air is around at the moment—and quite a bit of overselling—about advances in genetics, personalised genomics, and gene therapy. Only a small part of the variance in human illness is explained by genetics; most is explained by lifestyle, behaviour, and social factors such as poverty. Yet large sums are spent in a quixotic pursuit of the genetic basis for everything.
The hope—some say fear—is that we will be able to use advances in medical technology to reshape the genome of individual patients, curing ailments by changing somatic genes. Some even hope that we will be able to modify our species for the better by introducing changes into our germline.
Ethicists hotly debate this topic, arguing about the case for or against "perfection." Do we have the right to develop technologies that would allow us to change the human genome? Some would say this is a duty.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+